Irregular profile [Outliers]

posted by Dr_Dan  – Germany, 2013-05-06 16:05 (4061 d 02:30 ago) – Posting: # 10548
Views: 4,161

Dr sridevi
Exclusion of data cannot be accepted on the basis of statistical analysis or for pharmacokinetic reasons alone, because it is impossible to distinguish the formulation effects from other effects influencing the pharmacokinetics.
An outlier test is not an expectation of the medicines agencies but outliers could be shown by a box plot. This would allow the medicines agencies to compare the data between them. However, since it is the test product it will be hard to justify the exclusion of the subject from statistical analysis.
Kind regards and good luck

Kind regards and have a nice day

Complete thread:

UA Flag
 Admin contact
23,057 posts in 4,840 threads, 1,641 registered users;
107 visitors (0 registered, 107 guests [including 6 identified bots]).
Forum time: 18:36 CEST (Europe/Vienna)

You should treat as many patients as possible with the new drugs
while they still have the power to heal.    Armand Trousseau

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz